Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 26 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 60 actions collected · 60 in the last 12 months.
Auto-generated summary combining US and Korean research and earnings · not investment advice
AbbVie is currently trading at $285.42, slightly above its average price target of $282.61. While multiple institutions maintain Buy and Overweight ratings alongside recent upgrades, Neutral ratings from firms like UBS and conservative price targets as low as $200 also coexist, with notable quarterly EPS volatility observed.
Divergence: While most brokerages maintain or have raised their Buy ratings, UBS and BNP Paribas hold Neutral ratings with the lowest price target open down to $200, highlighting divergent institutional views.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 11. 03. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2026. 11. 03. | Leerink Partners | — | Maintain | Outperform → Outperform | — | Leerink Partners: Outperform |
| 2026. 11. 03. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2026. 11. 02. | Guggenheim | — | Maintain | Buy → Buy | — | Guggenheim: Buy |
| 2026. 11. 02. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2026. 11. 02. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2026. 11. 02. | Canaccord Genuity | — | Maintain | Buy → Buy | — | Canaccord Genuity: Buy |
| 2026. 11. 02. | Cantor Fitzgerald | — | Maintain | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
| 2026. 10. 24. | Goldman Sachs | — | Maintain | Neutral → Neutral | — | Goldman Sachs: Neutral |
| 2026. 10. 21. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 10. 13. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2026. 10. 10. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2026. 10. 09. | Guggenheim | — | Maintain | Buy → Buy | — | Guggenheim: Buy |
| 2026. 10. 09. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2026. 10. 08. | Cantor Fitzgerald | — | Maintain | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
| 2026. 10. 07. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2026. 10. 06. | Scotiabank | — | Maintain | Sector Outperform → Sector Outperform | — | Scotiabank: Sector Outperform |
| 2026. 09. 10. | HSBC | — | Maintain | Buy → Buy | — | HSBC: Buy |
| 2026. 08. 21. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2026. 08. 17. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2026. 08. 14. | Wolfe Research | — | Upgrade | Peer Perform → Outperform | — | Wolfe Research: Peer Perform → Outperform |
| 2026. 08. 12. | BNP Paribas | — | Maintain | Neutral → Neutral | — | BNP Paribas: Neutral |
| 2026. 08. 11. | Evercore ISI Group | — | Maintain | Outperform → Outperform | — | Evercore ISI Group: Outperform |
| 2026. 08. 06. | Berenberg | — | Maintain | Buy → Buy | — | Berenberg: Buy |
| 2026. 08. 05. | Erste Group | — | Upgrade | Hold → Buy | — | Erste Group: Hold → Buy |
| 2026. 08. 04. | Guggenheim | — | Maintain | Buy → Buy | — | Guggenheim: Buy |
| 2026. 08. 04. | Canaccord Genuity | — | Maintain | Buy → Buy | — | Canaccord Genuity: Buy |
| 2026. 08. 03. | Cantor Fitzgerald | — | Maintain | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
| 2026. 08. 03. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2026. 07. 31. | TD Cowen | — | Maintain | Buy → Buy | — | TD Cowen: Buy |
| 2026. 07. 31. | William Blair | — | Maintain | Buy → Buy | — | William Blair: Buy |
| 2026. 07. 29. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 07. 22. | Canaccord Genuity | — | Maintain | Buy → Buy | — | Canaccord Genuity: Buy |
| 2026. 07. 16. | Citigroup | — | Maintain | Neutral → Neutral | — | Citigroup: Neutral |
| 2026. 07. 14. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2026. 07. 13. | BMO Capital | — | Maintain | Outperform → Outperform | — | BMO Capital: Outperform |
| 2026. 07. 11. | B of A Securities | — | Maintain | Buy → Buy | — | B of A Securities: Buy |
| 2026. 07. 10. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2026. 07. 10. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2026. 07. 09. | Guggenheim | — | Maintain | Buy → Buy | — | Guggenheim: Buy |
| 2026. 07. 09. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2026. 07. 06. | Cantor Fitzgerald | — | Maintain | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
| 2026. 06. 24. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2026. 06. 23. | Canaccord Genuity | — | Maintain | Buy → Buy | — | Canaccord Genuity: Buy |
| 2026. 05. 16. | Evercore ISI Group | — | Maintain | Outperform → Outperform | — | Evercore ISI Group: Outperform |
| 2026. 05. 15. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2026. 05. 04. | Evercore ISI Group | — | Maintain | Outperform → Outperform | — | Evercore ISI Group: Outperform |
| 2026. 05. 02. | Guggenheim | — | Maintain | Buy → Buy | — | Guggenheim: Buy |
| 2026. 05. 01. | Canaccord Genuity | — | Maintain | Buy → Buy | — | Canaccord Genuity: Buy |
| 2026. 05. 01. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2026. 04. 30. | Cantor Fitzgerald | — | Maintain | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
| 2026. 04. 24. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2026. 04. 22. | Canaccord Genuity | — | Initiate coverage | — → Buy | — | Canaccord Genuity: Buy |
| 2026. 04. 10. | Guggenheim | — | Maintain | Buy → Buy | — | Guggenheim: Buy |
| 2026. 04. 08. | Cantor Fitzgerald | — | Maintain | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
| 2026. 02. 25. | RBC Capital | — | Initiate coverage | — → Outperform | — | RBC Capital: Outperform |
| 2026. 02. 20. | Barclays | — | Initiate coverage | — → Overweight | — | Barclays: Overweight |
| 2026. 02. 18. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2026. 02. 17. | Freedom Broker | — | Maintain | Buy → Buy | — | Freedom Broker: Buy |
| 2026. 02. 06. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
